Skip to main content
Fig. 8 | BMC Complementary Medicine and Therapies

Fig. 8

From: Identifying potential therapeutic targets of mulberry leaf extract for the treatment of type 2 diabetes: a TMT-based quantitative proteomic analysis

Fig. 8

Validation of the expressions of ApoA1 and ApoA4 by Western blot analysis. A The western blotting assay was performed to measure the expression of ApoA1 and ApoA4 in the skeletal muscle of rats. Relative expression of ApoA1 (B) and ApoA4 (C) were quantified. Data were shown as mean ± SD (n = 9). *P < 0.05, **P < 0.01 vs. normal group; #P < 0.05, ##P < 0.01 vs. T2DM group. T2DM Type 2 diabetes mellitus, MLE Mulberry leaf extract. Full-length blots are presented in Supplementary Figure S1

Back to article page